Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 301.45
-6.15 (-2.00%)
Sep 11, 2026, 3:15 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 7.13 billion as of September 11, 2026. Its market cap has increased by 183.77% in one year.
Market Cap
7.13B
Enterprise Value
7.49B
Revenue
1.43B
Ranking
n/a
PE Ratio
92.92
Stock Price
301.45
ChartMarket Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 7.13B, an increase of 65,432.60%. That is a compound annual growth rate of 169.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 7.13B | 100.01% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 25.64B |
| Windlas Biotech | 23.58B |
| Indoco Remedies | 21.34B |
| Beta Drugs | 21.28B |
| Jagsonpal Pharmaceuticals | 15.52B |
| Sigachi Industries | 14.35B |
| Anlon Healthcare | 8.65B |
| Amanta Healthcare | 7.83B |